Edgerton Zachary, Perini Alessandro Paoletti, Horton Rodney, Trivedi Chintan, Santangeli Pasquale, Bai Rong, Gianni Carola, Mohanty Sanghamitra, Burkhardt J David, Gallinghouse G Joseph, Sanchez Javier E, Bailey Shane, Lane Maegen, DI Biase Luigi, Santoro Francesco, Price Justin, Natale Andrea
Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Department of Heart and Vessels, University of Florence, Florence, Italy.
J Cardiovasc Electrophysiol. 2016 May;27(5):524-30. doi: 10.1111/jce.12926. Epub 2016 Feb 25.
Ablation of longstanding persistent atrial fibrillation (LSPAF) is the most challenging procedure in the treatment of AF, either by surgical or by percutaneous approach.
We investigated the difference in success and complication rates between combined surgical epicardial and endocardial catheter ablation procedure and our standard endocardial ablation procedure.
Twenty-four consecutive patients (group 1) with LSPAF and enlarged left atrium (>4.5 cm) underwent a combined procedure, consisting of surgical, closed-chest, epicardial, radiofrequency ablation (nContact, NC, USA) via pericardial access, and concomitant endocardial ablation (hybrid procedure). Procedural complications and long-term outcomes were compared to those of 35 consecutive patients who refused the hybrid procedure and underwent standard endocardial only ablation (group 2). Baseline characteristics were comparable. In group 1, 1 patient (4.2%) developed post-procedural cardio-embolic stroke and 3 (12.5%) died (1 atrio-esophageal fistula, 1 fatal stroke, 1 of unknown cause in early follow-up), while no strokes or deaths occurred in group 2. Overall complication rates were higher for group 1 (P = 0.036). At 24-month follow-up, 4 (19%) patients in group 1 and 19 (54.3%) in group 2 were arrhythmia-free after a single procedure, on or off antiarrhythmic drugs (P<0.001). Total procedural time (276.9 ± 63.5 vs. 203.15 ± 67.3 minutes) and length of hospital stay (5 [IQR 3-8] vs. 1 [IQR 1-3] days were significantly shorter for group 2 (P <0.001).
In patients with LSPAF and enlarged left atrium, a concomitant combined surgical/endocardial ablation approach increases complication rate and does not improve outcomes when compared to extensive endocardial ablation only.
无论是通过外科手术还是经皮途径,消融长期持续性心房颤动(LSPAF)都是房颤治疗中最具挑战性的操作。
我们研究了联合外科心外膜和心内膜导管消融术与我们的标准心内膜消融术在成功率和并发症发生率上的差异。
连续24例LSPAF且左心房增大(>4.5 cm)的患者(第1组)接受了联合手术,包括通过心包穿刺进行的外科闭式心外膜射频消融(nContact,美国)以及同期的心内膜消融(杂交手术)。将手术并发症和长期结果与35例拒绝杂交手术并仅接受标准心内膜消融的连续患者(第2组)进行比较。基线特征具有可比性。在第1组中,1例患者(4.2%)发生术后心脏栓塞性中风,3例(12.5%)死亡(1例为心房食管瘘,1例为致命性中风,1例在早期随访中死因不明),而第2组未发生中风或死亡。第1组的总体并发症发生率更高(P = 0.036)。在24个月的随访中,第1组有4例(19%)患者在单次手术后无论是否使用抗心律失常药物均无心律失常发作,第2组有19例(54.3%)患者无心律失常发作(P<0.001)。第2组的总手术时间(276.9±63.5 vs. 203.15±67.3分钟)和住院时间(5天[四分位间距3 - 8] vs. 第1天[四分位间距1 - 3])明显更短(P <0.001)。
对于LSPAF且左心房增大的患者,与仅进行广泛的心内膜消融相比,同期联合外科/心内膜消融方法会增加并发症发生率且不能改善治疗效果。